IqYmune for CIDP.
In: Neurology Alert, Jg. 40 (2020-11-01), Heft 2, S. 1-2
academicJournal
Zugriff:
IqYmune is a highly purified 10% concentration of human immunoglobulin obtained from healthy volunteers. It appears to have similar efficacy in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) as conventional intravenous immunoglobulin, with 76% of the study patients showing a significant improvement in a standardized disability score. [ABSTRACT FROM AUTHOR]
Titel: |
IqYmune for CIDP.
|
---|---|
Autor/in / Beteiligte Person: | AHC, MEDIA |
Zeitschrift: | Neurology Alert, Jg. 40 (2020-11-01), Heft 2, S. 1-2 |
Veröffentlichung: | 2020 |
Medientyp: | academicJournal |
ISSN: | 0741-4234 (print) |
Schlagwort: |
|
Sonstiges: |
|